The rationale and design of the national peripartum cardiomyopathy registries in Turkey: The ARTEMIS-I and ARTEMIS-II studies

Basit Öğe Kaydı
dc.contributor.authorKayikcioglu, Meral
dc.contributor.authorTokgozoglu, Lale
dc.contributor.authorMutluer, Ferit Onur
dc.contributor.authorUral, Dilek
dc.contributor.authorBiteker, Murat
dc.date.accessioned2019-10-27T10:46:17Z
dc.date.available2019-10-27T10:46:17Z
dc.date.issued2018
dc.departmentEge Üniversitesien_US
dc.description.abstractObjective: Peripartum cardiomyopathy (PPCM) is left ventricular (LV) systolic dysfunction with an ejection fraction of <= 45% occurring in the later stages of pregnancy or soon after delivery. Although various risk factors have been identified, the exact cause of the disease is unknown. Unlike most countries in the European region, Turkey has yet to determine the current PPCM burden. A registry for this purpose does not exist. To close this gap, the A RegisTry of pEripartuM cardIomyopathy in Turkish patientS (ARTEMIS-I and ARTEMIS-II), was planned and endorsed by the Turkish Society of Cardiology. The aim of this manuscript is to describe the rationale and design of the ARTEMIS-I and ARTEMIS-II registries. Methods: ARTEMIS was designed to be the nationwide PPCM registry of Turkey, with the goal of identifying problems and opportunities while improving quality and consistency in the medical care of PPCM patients. A second goal is to determine the clinical characteristics pertinent to patients in this region. The ARTEMIS registry will consist of 2 arms. All secondary and tertiary cardiology centers have been electronically invited to participate in ARTEMIS-I, which will be conducted to assess the current standard of care and outcome measures. Centers will be asked to enroll PPCM patients admitted to their clinic in last 5 years retrospectively. Eligibility criteria will consist of pregnant or early postpartum woman without a previous history of heart failure (HF) or known pathology associated with HF, LV ejection fraction <= 45%, and exclusion of other causes of LV systolic dysfunction. ARTEMIS-II will consist of the prospective enrollment of patients. Conclusion: The nationwide PPCM registries, ARTEMIS-I and ARTEMIS-II, are designed to determine the current status of medical care, provide insights into nature of the disease, and suggest solutions on how to improve care and outcomes in these patients.en_US
dc.description.sponsorshipAbbottAbbott Laboratories; Abdi Ibrahim; Actelion; Aegerion; AmgenAmgen; Bayer ScheringBayer AG; MerckMerck & Company; SanofiSanofi-Aventis; PfizerPfizer; Recordati; Astra; NovartisNovartis; Daiichi SankyoDaiichi Sankyo Company Limited; ServierServier; Boehringer IngelheimBoehringer Ingelheim; BayerBayer AG; GlaxoSmithKlineGlaxoSmithKline; Menarini; Kowa; Synagevaen_US
dc.description.sponsorshipProf. Meral Kayikcioglu, M.D., has received honoraria (lectures and counseling) and / or research funding from Abbott, Abdi Ibrahim, Actelion, Aegerion, Amgen, Bayer Schering, Merck, Sanofi, Pfizer, Recordati; Prof. Lale Tokgozoglu, M.D., has received honoraria / consultancy fees from Merck, Amgen, Astra, Novartis, Abbott, Daiichi Sankyo, Pfizer, Actelion, Servier, Sanofi, Boehringer Ingelheim, Bayer, GlaxoSmithKline, Menarini, Kowa, Aegerion, and Synageva; Ferit Onur Mutluer, M.D., None; Prof. Dilek Ural, M.D., has received honoraria (for lectures and consultancy) from Abdi Ibrahim, Amgen, Merck, and Novartis during the last 2 years; Assoc. Dr. Murat Biteker, M.D., has received honoraria (for lectures and consultancy) from Abbott, Abdi Ibrahim, Bayer, and Pfizer for the last 2 years.en_US
dc.identifier.doi10.5543/tkda.2018.53248en_US
dc.identifier.endpage46en_US
dc.identifier.issn1016-5169
dc.identifier.issue1en_US
dc.identifier.pmid29339690en_US
dc.identifier.startpage39en_US
dc.identifier.urihttps://doi.org/10.5543/tkda.2018.53248
dc.identifier.urihttps://hdl.handle.net/11454/31276
dc.identifier.volume46en_US
dc.identifier.wosWOS:000429103400007en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTurkish Soc Cardiologyen_US
dc.relation.ispartofTurk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPeripartum cardiomyopathyen_US
dc.subjectregistryen_US
dc.subjectTurkeyen_US
dc.titleThe rationale and design of the national peripartum cardiomyopathy registries in Turkey: The ARTEMIS-I and ARTEMIS-II studiesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu